Daniel Yerly
- Pharmacology top 1%
- Drug-Induced Adverse Reactions 22
- Rheumatology top 2%
- Urticaria and Related Conditions 15
- Dermatology top 2%
- Toxicology top 2%
- Immunology and Allergy top 5%
-
- Mast cells and histamine 6
- Immune Cell Function and Interaction 4
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Hepatitis C virus research 5
-
- Autoimmune Bullous Skin Diseases 4
-
- Asthma and respiratory diseases 4
- Co-authors
- Werner J. PichlerJacqueline AdamStefano FontanaJames YunKlara ErikssonChristoph SchlapbachNikhil YawalkarPeter M. Villiger
- Cited by
- PharmacologyRheumatologyDermatology
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Daniel Yerly
37 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 78
- Pharmacology 882
- Rheumatology 539
- Dermatology 293
- Toxicology 89
- Immunology and Allergy 131
Countries citing papers authored by Daniel Yerly
This map shows the geographic impact of Daniel Yerly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Yerly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Yerly more than expected).
Fields of papers citing papers by Daniel Yerly
This network shows the impact of papers produced by Daniel Yerly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Yerly. The network helps show where Daniel Yerly may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Yerly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 0 | |
| 8 | 2019 | 93 | |
| 9 | 2019 | 21 | |
| 10 | 2018 | 53 | |
| 11 | 2017 | 24 | |
| 12 | 2016 | 16 | |
| 13 | 2014 | 126 | |
| 14 | 2014 | 58 | |
| 15 | 2014 | 59 | |
| 16 | 2011 | 21 | |
| 17 | 2011 | 36 | |
| 18 | 2010 | 118 | |
| 19 | 2009 | 66 | |
| 20 | 2006 | 3 |
About Daniel Yerly
Daniel Yerly is a scholar working on Pharmacology, Rheumatology, Dermatology, Immunology and Hepatology, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (22 papers), Urticaria and Related Conditions (15 papers), Mast cells and histamine (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Hepatitis C virus research (5 papers), Autoimmune Bullous Skin Diseases (4 papers), Immune Cell Function and Interaction (4 papers) and Asthma and respiratory diseases (4 papers). The work is most often cited by research in Pharmacology (882 citations), Rheumatology (539 citations), Dermatology (293 citations), Toxicology (89 citations) and Immunology and Allergy (131 citations). Daniel Yerly has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Werner J. Pichler, Jacqueline Adam, Stefano Fontana, James Yun, Klara Eriksson, Christoph Schlapbach, Nikhil Yawalkar, Peter M. Villiger, Robert E. Hunger and Stephan Krähenbühl. Their work appears in journals such as Allergy, The Journal of Immunology, Allergology International, Lara D. Veeken and Swiss Medical Weekly.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.